Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
59,964,750
-
Total 13F shares
-
41,259,486
-
Share change
-
-1,287,010
-
Total reported value
-
$344,882,956
-
Put/Call ratio
-
88%
-
Price per share
-
$8.36
-
Number of holders
-
115
-
Value change
-
-$12,846,699
-
Number of buys
-
53
-
Number of sells
-
54
Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q1 2016
As of 31 Mar 2016,
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,259,486 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT CO, Palo Alto Investors, LLC, PAULSON & CO. INC., GREAT POINT PARTNERS LLC, MILLENNIUM MANAGEMENT LLC, Stonepine Capital Management, LLC, BlackRock Fund Advisors, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, and STATE STREET CORP.
This page lists
115
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.